TrademarkDir
GYNACAN
LIVE

Serial Number

97040530

Owner

12385236 CANADA INC.

Attorney

Ellen A. Andelman

First Use Date

Apr 22, 2024

Filing Date

Sep 22, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GYNACAN Trademark

Serial Number: 97040530 • Registration: 7458456

GYNACAN is a trademark filed by 12385236 CANADA INC. on September 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

12385236 CANADA INC. (4 trademarks)

305-4702 LOUIS-B.-MAYER STREET
LAVAL H7P 0L9 , CA

Entity Type: 03

Trademark Details

Filing Date

September 22, 2021

Registration Date

July 23, 2024

First Use Anywhere

April 22, 2024

First Use in Commerce

April 22, 2024

Published for Opposition

October 18, 2022

Goods & Services

Anti-infectives; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; herbal supplements for the treatment of infectious diseases; herbal supplements for the treatment of recurring vaginal infections, namely, candidiasis; pharmaceutical preparations for the prevention of recurring vaginal infections, namely, candidiasis; pharmaceutical preparations in the form of vegicapsules for vaginal use for the treatment of recurring vaginal infections; herbal dietary supplements for the prevention of infectious diseases, namely, candidiasis and associated symptoms

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 17, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 17, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 26, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 26, 2024 AITU
USE AMENDMENT FILED
Apr 29, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 29, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 30, 2023 EXRA
SOU EXTENSION 2 GRANTED
Nov 29, 2023 EX2G
SOU EXTENSION 2 FILED
Nov 29, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 29, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 19, 2023 EXRA
SOU EXTENSION 1 GRANTED
Apr 17, 2023 EX1G
SOU EXTENSION 1 FILED
Apr 17, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 17, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 13, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 18, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 13, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 13, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 13, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 13, 2022 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Sep 12, 2022 GPRN
PRIORITY ACTION E-MAILED
Sep 12, 2022 GPRA
PRIORITY ACTION WRITTEN
Sep 12, 2022 CPRA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 27, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2021 NWOS
NEW APPLICATION ENTERED
Sep 25, 2021 NWAP

Related Trademarks

More from this Owner

URIEXO

URIEXO

URIEXO

URIEXO

URIEXO

URIEXO

GYNATROF

GYNATROF

GYNALAC

GYNALAC